Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Harper

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Nephron|February 3, 2018
Vascular Endothelial Growth Factor-A165b Restores Normal Glomerular Water Permeability in a Diphtheria-Toxin Mouse Model of Glomerular InjuryMegan Stevens, Christopher R Neal, Andrew H J Salmon, et al.
Angiogenesis|October 3, 2014
The carboxyl terminus of VEGF-A is a potential target for anti-angiogenic therapyJames G Carter, Melissa V R Gammons, Gopinath Damodaran, et al.
Cardiovascular Research|March 20, 2009
Angiopoietin-1 alters microvascular permeability coefficients in vivo via modification of endothelial glycocalyxAndrew H J Salmon, Christopher R Neal, Leslie M Sage, et al.
American Journal of Physiology. Renal Physiology|August 24, 2007
Glomerular filtration into the subpodocyte space is highly restricted under physiological perfusion conditionsChristopher R Neal, P Robert Muston, David Njegovan, et al.
Microcirculation (New York, N.Y. : 1994)|July 26, 2006
VEGF and angiopoietin-1 stimulate different angiogenic phenotypes that combine to enhance functional neovascularization in adult tissueAndrew V Benest, Andrew H Salmon, Wenying Wang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 23, 2007
Mammary alveolar development during lactation is inhibited by the endogenous antiangiogenic growth factor isoform, VEGF165bYan Qiu, Heather Bevan, Sudath Weeraperuma, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 16, 2010
VEGF in the lung: a role for novel isoformsJulia Varet, Samantha K Douglas, Laura Gilmartin, et al.
American Journal of Cancer Research|August 14, 2015
Circulating levels of anti-angiogenic VEGF-A isoform (VEGF-Axxxb) in colorectal cancer patients predicts tumour VEGF-A ratiosJohn Bunni, Golda Shelley-Fraser, Kirsty Stevenson, et al.
American Journal of Physiology. Renal Physiology|December 3, 2003
Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and proteinTai-Gen Cui, Rebecca R Foster, Moin Saleem, et al.
Cancer Research|July 19, 2002
VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinomaDavid O Bates, Tai-Gen Cui, Joanne M Doughty, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Nephron|February 3, 2018
Vascular Endothelial Growth Factor-A165b Restores Normal Glomerular Water Permeability in a Diphtheria-Toxin Mouse Model of Glomerular InjuryMegan Stevens, Christopher R Neal, Andrew H J Salmon, et al.
Angiogenesis|October 3, 2014
The carboxyl terminus of VEGF-A is a potential target for anti-angiogenic therapyJames G Carter, Melissa V R Gammons, Gopinath Damodaran, et al.
Cardiovascular Research|March 20, 2009
Angiopoietin-1 alters microvascular permeability coefficients in vivo via modification of endothelial glycocalyxAndrew H J Salmon, Christopher R Neal, Leslie M Sage, et al.
American Journal of Physiology. Renal Physiology|August 24, 2007
Glomerular filtration into the subpodocyte space is highly restricted under physiological perfusion conditionsChristopher R Neal, P Robert Muston, David Njegovan, et al.
Microcirculation (New York, N.Y. : 1994)|July 26, 2006
VEGF and angiopoietin-1 stimulate different angiogenic phenotypes that combine to enhance functional neovascularization in adult tissueAndrew V Benest, Andrew H Salmon, Wenying Wang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 23, 2007
Mammary alveolar development during lactation is inhibited by the endogenous antiangiogenic growth factor isoform, VEGF165bYan Qiu, Heather Bevan, Sudath Weeraperuma, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 16, 2010
VEGF in the lung: a role for novel isoformsJulia Varet, Samantha K Douglas, Laura Gilmartin, et al.
American Journal of Cancer Research|August 14, 2015
Circulating levels of anti-angiogenic VEGF-A isoform (VEGF-Axxxb) in colorectal cancer patients predicts tumour VEGF-A ratiosJohn Bunni, Golda Shelley-Fraser, Kirsty Stevenson, et al.
American Journal of Physiology. Renal Physiology|December 3, 2003
Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and proteinTai-Gen Cui, Rebecca R Foster, Moin Saleem, et al.
Cancer Research|July 19, 2002
VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinomaDavid O Bates, Tai-Gen Cui, Joanne M Doughty, et al.
Pageof 7